These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 21948321

  • 21. Modification of Three-Phase Drug Release Mode of Octreotide PLGA Microspheres by Microsphere-Gel Composite System.
    Wang T, Zhang C, Zhong W, Yang X, Wang A, Liang R.
    AAPS PharmSciTech; 2019 Jun 21; 20(6):228. PubMed ID: 31227940
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.
    Wu XS.
    Artif Cells Blood Substit Immobil Biotechnol; 2004 Jun 21; 32(4):575-91. PubMed ID: 15974184
    [Abstract] [Full Text] [Related]

  • 23. A novel in vitro release technique for peptide containing biodegradable microspheres.
    Kostanski JW, DeLuca PP.
    AAPS PharmSciTech; 2000 Mar 09; 1(1):E4. PubMed ID: 14727853
    [Abstract] [Full Text] [Related]

  • 24. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres.
    Blanco-Príeto MJ, Besseghir K, Zerbe O, Andris D, Orsolini P, Heimgartner F, Merkle HP, Gander B.
    J Control Release; 2000 Jun 15; 67(1):19-28. PubMed ID: 10773325
    [Abstract] [Full Text] [Related]

  • 25. Sophoridine-loaded PLGA microspheres for lung targeting: preparation, in vitro, and in vivo evaluation.
    Wang W, Cai Y, Zhang G, Liu Y, Sui H, Park K, Wang H.
    Drug Deliv; 2016 Nov 15; 23(9):3674-3680. PubMed ID: 27689622
    [Abstract] [Full Text] [Related]

  • 26. Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.
    Vaishya RD, Mandal A, Patel S, Mitra AK.
    Int J Pharm; 2015 Dec 30; 496(2):676-88. PubMed ID: 26561725
    [Abstract] [Full Text] [Related]

  • 27. Ramizol® encapsulation into extended release PLGA micro- and nanoparticle systems for subcutaneous and intramuscular administration: in vitro and in vivo evaluation.
    Wright L, Rao S, Thomas N, Boulos RA, Prestidge CA.
    Drug Dev Ind Pharm; 2018 Sep 30; 44(9):1451-1457. PubMed ID: 29619851
    [Abstract] [Full Text] [Related]

  • 28. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L, Cheng J, Chi Q, Qie J, Liu Y, Mei X.
    Chem Pharm Bull (Tokyo); 2006 Sep 30; 54(9):1259-65. PubMed ID: 16946531
    [Abstract] [Full Text] [Related]

  • 29. Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres.
    Vivek K, Reddy LH, Murthy RS.
    Pharm Dev Technol; 2007 Sep 30; 12(1):79-88. PubMed ID: 17484147
    [Abstract] [Full Text] [Related]

  • 30. Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation.
    Wu J, Williams GR, Branford-White C, Li H, Li Y, Zhu LM.
    Eur J Pharm Sci; 2016 Sep 20; 92():28-38. PubMed ID: 27343696
    [Abstract] [Full Text] [Related]

  • 31. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization.
    Chen W, Lu DR.
    J Microencapsul; 1999 Sep 20; 16(5):551-63. PubMed ID: 10499836
    [Abstract] [Full Text] [Related]

  • 32. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM, Kim SW.
    Pharm Res; 2004 Feb 20; 21(2):339-43. PubMed ID: 15032317
    [Abstract] [Full Text] [Related]

  • 33. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG, Mallery SR, Schwendeman SP.
    Pharm Res; 2008 Mar 20; 25(3):586-97. PubMed ID: 17891553
    [Abstract] [Full Text] [Related]

  • 34. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
    Jordan F, Naylor A, Kelly CA, Howdle SM, Lewis A, Illum L.
    J Control Release; 2010 Jan 25; 141(2):153-60. PubMed ID: 19772878
    [Abstract] [Full Text] [Related]

  • 35. Microspheres prepared with PLGA blends for delivery of dexamethasone for implantable medical devices.
    Wang Y, Gu B, Burgess DJ.
    Pharm Res; 2014 Feb 25; 31(2):373-81. PubMed ID: 23949251
    [Abstract] [Full Text] [Related]

  • 36. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z, Sun F, Shi Y, Jiang C, Meng Q, Teng L, Li Y.
    Chem Pharm Bull (Tokyo); 2009 Nov 25; 57(11):1251-6. PubMed ID: 19881277
    [Abstract] [Full Text] [Related]

  • 37. Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.
    Guo Y, Yang Y, He L, Sun R, Pu C, Xie B, He H, Zhang Y, Yin T, Wang Y, Tang X.
    Pharm Res; 2017 Oct 25; 34(10):2211-2222. PubMed ID: 28741064
    [Abstract] [Full Text] [Related]

  • 38. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M, Sakai Y, Yoshida M, Haraguchi T, Morisaki T, Uchida T.
    J Pharm Pharmacol; 2011 Mar 25; 63(3):362-8. PubMed ID: 21749383
    [Abstract] [Full Text] [Related]

  • 39. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.
    Gabor F, Ertl B, Wirth M, Mallinger R.
    J Microencapsul; 1999 Mar 25; 16(1):1-12. PubMed ID: 9972498
    [Abstract] [Full Text] [Related]

  • 40. Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.
    Shen J, Burgess DJ.
    Int J Pharm; 2012 Jan 17; 422(1-2):341-8. PubMed ID: 22016033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.